Zoetis (ZTS) EBITDA (2012 - 2026)
Zoetis' EBITDA came in at $1.01 billion for Q3 2026, down 6.7% from $1.09 billion a year earlier and down 5.5% from the prior quarter.
Zoetis (ZTS) EBITDA (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zoetis reported EBITDA of $4.02 billion, down 1.7% year-over-year; for FY2025, it came in at $4.16 billion, up 4.6% from FY2024.
- EBITDA has increased in each of the last ten years, with a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- Going back by year, EBITDA was $3.98 billion in FY2024 (+8.8%), $3.66 billion in FY2023 (+3.5%), $3.53 billion in FY2022 (+4.8%) and $3.37 billion in FY2021 (+18.4%).
- The five-year range for quarterly EBITDA is $749 million (Q4 2021) to $1.12 billion (Q2 2025).
- Year-over-year, EBITDA has declined for three consecutive quarters, with growth averaging 1.6% over the last eight quarters.
- The fastest year-over-year change in EBITDA over five years came in Q4 2021 (growth of 13.7%), and the weakest in Q1 2023 (a decline of 8.3%).
- Business Quant data shows ZTS's EBITDA at $1.07 billion (Q2 2026), $950 million (Q1 2026) and $988 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Zoetis | 34.65 Bn | 27.05 Bn | 1.69 Bn | 1.01 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.01 Bn |
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 950.00 Mn |
| Dec 31, 2025 | 988.00 Mn |
| Sep 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 963.00 Mn |
| Dec 31, 2024 | 920.00 Mn |
| Sep 30, 2024 | 1.07 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 960.00 Mn |
| Dec 31, 2023 | 864.00 Mn |
| Sep 30, 2023 | 944.00 Mn |
| Jun 30, 2023 | 984.00 Mn |
| Mar 31, 2023 | 864.00 Mn |
| Dec 31, 2022 | 842.00 Mn |
| Sep 30, 2022 | 869.00 Mn |
| Jun 30, 2022 | 879.00 Mn |
| Mar 31, 2022 | 942.00 Mn |
| Dec 31, 2021 | 749.00 Mn |
Zoetis EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ZTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();